Correction

Genitourinary syndrome of menopause

Cleveland Clinic Journal of Medicine November 2018, 85 (11) 860;

In the article by A.C. Moreno, S.K. Sikka, and H.L. Thacker, Genitourinary syndrome of menopause in breast cancer survivors: Treatments are available, Cleve Clin J Med 2018; 85(10):760–766, doi:10.3949/ccjm.85a.17108), Table 2 incorrectly stated that prasterone is contraindicated in women with known or suspected breast cancer. This correction has been made online. The corrected table appears below:

View this table:
TABLE 2

FDA-approved labeling notes for treatments for genitourinary syndrome of menopause

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects